Login to Your Account

U.K.'s NHS widens biosimilars use plans

By Nuala Moran
Staff Writer

Monday, August 8, 2016

LONDON – The U.K. is expanding the scope of its biosimilars adoption program as experience of using them grows, more products come onto the market and use begins to expand beyond hospital settings and into primary care.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription